{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T16:13:50Z","timestamp":1792512830776,"version":"4.5.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2017,9,25]],"date-time":"2017-09-25T00:00:00Z","timestamp":1506297600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100008130","name":"Helsinn Therapeutics","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008130","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Health Econ"],"published-print":{"date-parts":[[2019,3]]},"DOI":"10.1007\/s10198-017-0930-6","type":"journal-article","created":{"date-parts":[[2017,9,25]],"date-time":"2017-09-25T01:32:12Z","timestamp":1506303132000},"page":"181-193","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Mapping health-related quality of life scores from FACT-G, FAACT, and FACIT-F onto preference-based EQ-5D-5L utilities in non-small cell lung cancer cachexia"],"prefix":"10.1007","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0092-5970","authenticated-orcid":false,"given":"Michela","family":"Meregaglia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ludovica","family":"Borsoi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Cairns","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosanna","family":"Tarricone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,9,25]]},"reference":[{"key":"930_CR1","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1016\/j.clnu.2008.06.013","volume":"27","author":"WJ Evans","year":"2008","unstructured":"Evans, W.J., Morley, J.E., Argil\u00e9s, J., et al.: Cachexia: a new definition. Clin. Nutr. 27, 793\u2013799 (2008)","journal-title":"Clin. Nutr."},{"key":"930_CR2","doi-asserted-by":"publisher","DOI":"10.1007\/s00520-016-3156-8","author":"K Takayama","year":"2016","unstructured":"Takayama, K., Atagi, S., Imamura, F., et al.: Quality of life and survival survey of cancer cachexia in advanced non-small cell lung cancer patients\u2014Japan nutrition and QOL survey in patients with advanced non-small cell lung cancer study. Supp. Care Cancer (2016). doi:\n                    10.1007\/s00520-016-3156-8","journal-title":"Supp. Care Cancer"},{"issue":"4","key":"930_CR3","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1016\/j.jpainsymman.2014.09.008","volume":"49","author":"TW Blanc Le","year":"2015","unstructured":"Le Blanc, T.W., Nipp, R.D., Rushing, C.N., et al.: Correlation between the international consensus definition of the Cancer Anorexia-Cachexia Syndrome (CACS) and patient-centered outcomes in advanced non-small cell lung cancer. J. Pain Symptom Manage. 49(4), 680\u2013689 (2015)","journal-title":"J. Pain Symptom Manage."},{"key":"930_CR4","doi-asserted-by":"publisher","first-page":"e200","DOI":"10.1038\/oncsis.2016.3","volume":"5","author":"PE Porporato","year":"2016","unstructured":"Porporato, P.E.: Understanding cachexia as a cancer metabolism syndrome. Oncogenesis 5, e200 (2016). doi:\n                    10.1038\/oncsis.2016.3","journal-title":"Oncogenesis"},{"key":"930_CR5","unstructured":"Functional Assessment of Chronic Illness Therapy. \n                    http:\/\/www.facit.org\/\n                    \n                  . Accessed Apr 2016"},{"key":"930_CR6","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1007\/s00520-015-2826-2","volume":"24","author":"S Blauwhoff-Buskermolen","year":"2016","unstructured":"Blauwhoff-Buskermolen, S., Ruijgrok, C., Ostelo, R.W., et al.: The assessment of anorexia in patients with cancer: cut-off values for the FAACT-A\/CS and the VAS for appetite. Supp. Care Cancer 24, 661\u2013666 (2016)","journal-title":"Supp. Care Cancer"},{"key":"930_CR7","unstructured":"European Quality of Life Group Association. \n                    http:\/\/www.euroqol.org\/\n                    \n                  . Accessed Apr 2016"},{"key":"930_CR8","volume-title":"Guide to the methods of technology appraisal","author":"National Institute for Health and Clinical Excellence (NICE)","year":"2008","unstructured":"National Institute for Health and Clinical Excellence (NICE): Guide to the methods of technology appraisal. NICE, London (2008)"},{"key":"930_CR9","doi-asserted-by":"publisher","DOI":"10.1186\/1477-7525-12-35","volume-title":"Mapping EORTC QLQ-C30 and QLQ-MY20 to EQ-5D in patients with multiple myeloma","author":"I Proskorovsky","year":"2014","unstructured":"Proskorovsky, I., Lewis, P., Williams, C.D., et al.: Mapping EORTC QLQ-C30 and QLQ-MY20 to EQ-5D in patients with multiple myeloma. DOI, Health Qual Life Outcomes (2014). doi:\n                    10.1186\/1477-7525-12-35"},{"key":"930_CR10","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.critrevonc.2015.12.008","volume":"99","author":"R Tarricone","year":"2016","unstructured":"Tarricone, R., Ricca, G., Nyanzi-Wakholi, B., Medina-Lara, A.: Impact of cancer anorexia-cachexia syndrome on health-related quality of life and resource utilization: a systematic review. Crit. Rev. Oncol. Hematol. 99, 49\u201362 (2016)","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"930_CR11","doi-asserted-by":"publisher","DOI":"10.1186\/1477-7525-11-203","author":"P Teckle","year":"2013","unstructured":"Teckle, P., McTaggart-Cowan, H., Van der Hoek, K., et al.: Mapping the FACT-G cancer-specific quality of life instrument to the EQ-5D and SF-6D. Health Qual. Life Outcomes (2013). doi:\n                    10.1186\/1477-7525-11-203","journal-title":"Health Qual. Life Outcomes"},{"key":"930_CR12","unstructured":"Health Economics Research Centre (HERC) database of mapping studies. University of Oxford. \n                    http:\/\/www.herc.ox.ac.uk\/downloads\/herc-database-of-mapping-studies\n                    \n                  . Accessed Apr 2016"},{"issue":"10","key":"930_CR13","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1007\/s40273-015-0312-9","volume":"33","author":"S Petrou","year":"2015","unstructured":"Petrou, S., Rivero-Arias, O., Dakin, H., et al.: The MAPS reporting statement for studies mapping onto generic preference-based outcome measures: explanation and elaboration. Pharmacoeconomics 33(10), 993\u20131011 (2015)","journal-title":"Pharmacoeconomics"},{"key":"930_CR14","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1016\/S1470-2045(15)00558-6","volume":"17","author":"JS Temel","year":"2016","unstructured":"Temel, J.S., Abernethy, A.P., Currow, D.C., et al.: Anamorelin in patients with non-small-cell lung cancer and cachexia (ROMANA 1 and ROMANA 2): results from two randomized, double-blind, phase 3 trials. Lancet Oncol. 17, 519\u2013531 (2016)","journal-title":"Lancet Oncol."},{"key":"930_CR15","doi-asserted-by":"crossref","unstructured":"Devlin N, Shah K, Feng Y, Mulhern B, van Hout B.: Valuing health-related quality of life: an EQ-5D-5L value set for England. Office of Health Economics (OHE), Research Paper 16\/01, January 2016 (unpublished article)","DOI":"10.1002\/hec.3564"},{"issue":"4","key":"930_CR16","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/j.jval.2016.01.003","volume":"19","author":"MM Versteegh","year":"2016","unstructured":"Versteegh, M.M., Vermeulen, K.M., Evers, S.M.A.A., Ardine de Wit, G., Prenger, R., Stolk, E.A.: Dutch tariff for the five-level version of EQ-5D. Value Health 19(4), 343\u2013352 (2016)","journal-title":"Value Health"},{"key":"930_CR17","doi-asserted-by":"publisher","DOI":"10.1177\/1094428104263672","author":"GA Ballinger","year":"2004","unstructured":"Ballinger, G.A.: Using generalized estimating equations for longitudinal data analysis. Org. Res. Methods (2004). doi:\n                    10.1177\/1094428104263672","journal-title":"Org. Res. Methods"},{"key":"930_CR18","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/303728","author":"M Wang","year":"2014","unstructured":"Wang, M.: Generalized estimating equations in longitudinal data analysis: a review and recent developments. Adv. Stat. (2014). doi:\n                    10.1155\/2014\/303728","journal-title":"Adv. Stat."},{"key":"930_CR19","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/j.jval.2013.12.005","volume":"17","author":"K Skaltsa","year":"2014","unstructured":"Skaltsa, K., Longworth, L., Ivanescu, C., Holmstrom, S.: Mapping the FACT-P to the preference-based EQ-5D questionnaire in metastatic castration-resistant prostate cancer. Value Health 17, 238\u2013244 (2014)","journal-title":"Value Health"},{"issue":"2","key":"930_CR20","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1177\/1536867X0700700205","volume":"7","author":"J Cui","year":"2007","unstructured":"Cui, J.: QIC program and model selection in GEE analyses. Stata J. 7(2), 209\u2013220 (2007)","journal-title":"Stata J."},{"issue":"5","key":"930_CR21","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1111\/j.1524-4733.2007.00195.x","volume":"10","author":"EQ Wu","year":"2007","unstructured":"Wu, E.Q., Mulani, P., Farrell, M.H., Sleep, D.: Mapping FACT-P and EORTC QLQ-C30 to patient health status measured by EQ-5D in metastatic hormone-refractory prostate cancer patients. Value Health 10(5), 408\u2013414 (2007)","journal-title":"Value Health"},{"issue":"9","key":"930_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3310\/hta18090","volume":"18","author":"L Longworth","year":"2014","unstructured":"Longworth, L., Yang, Y., Young, T., et al.: Use of generic and condition-specific measures of health-related quality of life in NICE decision-making: a systematic review, statistical modelling and survey. Health Technol. Assess. 18(9), 1\u2013224 (2014). doi:\n                    10.3310\/hta18090","journal-title":"Health Technol. Assess."},{"key":"930_CR23","doi-asserted-by":"publisher","DOI":"10.1186\/s12955-016-0455-1","author":"I Khan","year":"2016","unstructured":"Khan, I., Morris, S., Pashayan, N., Matata, B., Bashir, Z., Maguirre, J.: Comparing the mapping between EQ-5D-5L, EQ-5D-3L and the EORTC-QLQ-C30 in non-small cell lung cancer patients. Health Qual. Life Outcomes (2016). doi:\n                    10.1186\/s12955-016-0455-1","journal-title":"Health Qual. Life Outcomes"},{"key":"930_CR24","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1016\/j.jval.2010.09.011","volume":"14","author":"HJ Starkie","year":"2011","unstructured":"Starkie, H.J., Briggs, A.H., Chambers, M.G., Jones, P.: Predicting EQ-5D values using the SGRQ. Value Health 14, 354\u2013360 (2011)","journal-title":"Value Health"},{"key":"930_CR25","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s12955-014-0196-y","volume":"13","author":"DT Arnold","year":"2015","unstructured":"Arnold, D.T., Rowen, D., Versteegh, M.M., Morley, A., Hooper, C.E., Maskell, N.A.: Testing mapping algorithms of the cancer-specific EORTC QLQ-C30 onto EQ-5D in malignant mesothelioma. Health Qual. Life Outcomes 13, 6 (2015). doi:\n                    10.1186\/s12955-014-0196-y","journal-title":"Health Qual. Life Outcomes"},{"key":"930_CR26","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1186\/1477-7525-5-70","volume":"5","author":"AS Pickard","year":"2007","unstructured":"Pickard, A.S., Neary, M.P., Cella, D.: Estimation of minimally important differences in EQ-5D utility and VAS scores in cancer. Health Qual. Life Outcomes 5, 70 (2007)","journal-title":"Health Qual. Life Outcomes"},{"issue":"2","key":"930_CR27","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1111\/j.1524-4733.2008.00448.x","volume":"12","author":"YB Cheung","year":"2009","unstructured":"Cheung, Y.B., Thumboo, J., Gao, F., et al.: Mapping the English and Chinese versions of the Functional Assessment of Cancer Therapy-General to the EQ-5D utility index. Value Health 12(2), 371\u2013376 (2009)","journal-title":"Value Health"},{"key":"930_CR28","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1007\/s11136-014-0794-5","volume":"24","author":"J Diels","year":"2015","unstructured":"Diels, J., Hamberg, P., Ford, D., et al.: Mapping FACT-P to EQ-5D in a large cross-sectional study of metastatic castration-resistant prostate cancer patients. Qual. Life Res. 24, 591\u2013598 (2015)","journal-title":"Qual. Life Res."},{"key":"930_CR29","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1016\/j.jval.2011.04.003","volume":"14","author":"RL Askew","year":"2011","unstructured":"Askew, R.L., Swartz, R.J., Xing, Y., et al.: Mapping the FACT-Melanoma Quality-of-Life Scores to EQ-5D Health Utility Weights. Value Health 14, 900\u2013906 (2011)","journal-title":"Value Health"},{"key":"930_CR30","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1186\/s12955-014-0180-6","volume":"12","author":"YB Cheung","year":"2014","unstructured":"Cheung, Y.B., Luo, N., Ng, R., Lee, C.F.: Mapping the functional assessment of cancer therapy-breast (FACT-B) to the 5-level EuroQol Group\u2019s 5-dimension questionnaire (EQ-5D-5L) utility index in a multi-ethnic Asian population. Health Qual. Life Outcomes 12, 180 (2014). doi:\n                    10.1186\/s12955-014-0180-6","journal-title":"Health Qual. Life Outcomes"},{"issue":"4","key":"930_CR31","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1177\/0272989X11427761","volume":"32","author":"MM Versteegh","year":"2012","unstructured":"Versteegh, M.M., Leunis, A., Luime, J.J., Boggild, M., Uyl-de Groot, C.A., Stolk, E.A.: Mapping QLQ-C30, HAQ, and MSIS-29 on EQ-5D. Med. Decis. Mak. 32(4), 554\u2013568 (2012)","journal-title":"Med. Decis. Mak."},{"key":"930_CR32","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1016\/j.jval.2012.12.005","volume":"16","author":"S Kay","year":"2013","unstructured":"Kay, S., Tolley, K., Colayco, D., Khalaf, K., Anderson, P., Globe, D.: Mapping EQ-5D utility scores from the Incontinence Quality of Life Questionnaire among patients with neurogenic and idiopathic overactive bladder. Value Health 16, 394\u2013402 (2013)","journal-title":"Value Health"},{"issue":"1","key":"930_CR33","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.jval.2016.11.006","volume":"20","author":"AJ Wailoo","year":"2017","unstructured":"Wailoo, A.J., Hernandez-Alava, M., Manca, A., et al.: Mapping to estimate health-state utility from non-preference-based outcome measures: an ISPOR good practices for outcomes research task force report. Value Health 20(1), 18\u201327 (2017)","journal-title":"Value Health"},{"key":"930_CR34","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1186\/1477-7525-8-141","volume":"8","author":"MM Versteegh","year":"2010","unstructured":"Versteegh, M.M., Rowen, D., Brazier, J.A., Stolk, E.A.: Mapping onto Eq-5 D for patients in poor health. Health Qual. Life Outcomes 8, 141 (2010). doi:\n                    10.1186\/1477-7525-8-141","journal-title":"Health Qual. Life Outcomes"},{"issue":"3","key":"930_CR35","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1016\/j.jval.2011.12.014","volume":"15","author":"M Hern\u00e1ndez Alava","year":"2012","unstructured":"Hern\u00e1ndez Alava, M., Wailoo, A.J., Ara, R.: Tails from the peak district: adjusted limited dependent variable mixture models of EQ-5D questionnaire health state utility values. Value Health 15(3), 550\u2013561 (2012)","journal-title":"Value Health"},{"issue":"23","key":"930_CR36","doi-asserted-by":"publisher","first-page":"3868","DOI":"10.1200\/JCO.2009.23.1183","volume":"27","author":"NJ Meropol","year":"2009","unstructured":"Meropol, N.J., Schrag, D., Smith, T.J., et al.: American Society of Clinical Oncology guidance statement: the cost of cancer care. J. Clin. Oncol. 27(23), 3868\u20133874 (2009)","journal-title":"J. Clin. Oncol."}],"container-title":["The European Journal of Health Economics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10198-017-0930-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10198-017-0930-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10198-017-0930-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,20]],"date-time":"2019-09-20T03:41:52Z","timestamp":1568950912000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10198-017-0930-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9,25]]},"references-count":36,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,3]]}},"alternative-id":["930"],"URL":"https:\/\/doi.org\/10.1007\/s10198-017-0930-6","relation":{},"ISSN":["1618-7598","1618-7601"],"issn-type":[{"value":"1618-7598","type":"print"},{"value":"1618-7601","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,9,25]]},"assertion":[{"value":"1 September 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 August 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 September 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}